Cargando…
Bacterial expression of human kynurenine 3-monooxygenase: Solubility, activity, purification()
Kynurenine 3-monooxygenase (KMO) is an enzyme central to the kynurenine pathway of tryptophan metabolism. KMO has been implicated as a therapeutic target in several disease states, including Huntington’s disease. Recombinant human KMO protein production is challenging due to the presence of transmem...
Autores principales: | Wilson, K., Mole, D.J., Binnie, M., Homer, N.Z.M., Zheng, X., Yard, B.A., Iredale, J.P., Auer, M., Webster, S.P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academic Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3969302/ https://www.ncbi.nlm.nih.gov/pubmed/24316190 http://dx.doi.org/10.1016/j.pep.2013.11.015 |
Ejemplares similares
-
Overexpression of human kynurenine-3-monooxygenase protects against 3-hydroxykynurenine-mediated apoptosis through bidirectional nonlinear feedback
por: Wilson, K, et al.
Publicado: (2016) -
Kynurenine 3-monooxygenase is a critical regulator of renal ischemia–reperfusion injury
por: Zheng, Xiaozhong, et al.
Publicado: (2019) -
Diclofenac Identified as a Kynurenine 3-Monooxygenase
Binder and Inhibitor by Molecular Similarity Techniques
por: Shave, Steven, et al.
Publicado: (2018) -
Kynurenine–3–monooxygenase inhibition prevents multiple organ failure in rodent models of acute pancreatitis
por: Mole, Damian J, et al.
Publicado: (2016) -
The Kynurenine Pathway and Kynurenine 3-Monooxygenase Inhibitors
por: Hughes, Tamera D., et al.
Publicado: (2022)